SCHEMBL312706

SCHEMBL312706

CCOC(=O)Nc1cc(O)cc(O)c1-c1cc(=O)c2ccccc2o1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.61
HPGD P15428 6/20 0.61
HSD17B10 Q99714 2/20 0.61
LMNA P02545 2/20 0.61
TNKS O95271 5/20 0.53
MAOB P27338 2/20 0.50
CSNK2A2 P19784 2/20 0.49
CSNK2B P67870 2/20 0.49
CSNK2A1 P68400 2/20 0.49
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
CYP3A4 P08684 3/20 0.49
CYP2C9 P11712 2/20 0.49
CYP2C19 P33261 2/20 0.49
L3MBTL1 Q9Y468 2/20 0.46
SMN1; SMN2 Q16637 3/20 0.45
POLB P06746 2/20 0.45
RAB9A P51151 2/20 0.45
NPC1 O15118 2/20 0.45
BCHE P06276 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL311739 0.86 KDM4E (0.44) KDM4EHPGDHSD17B10LMNATNKS
SCHEMBL313350 0.86 KDM4E (0.44) KDM4EHPGDHSD17B10LMNATNKS
SCHEMBL324201 0.85 HPGD (0.61) KDM4EHPGDHSD17B10LMNATNKS
SCHEMBL312777 0.85 HPGD (0.43) KDM4EHPGDHSD17B10LMNATNKS
SCHEMBL311129 0.84 HPGD (0.63) KDM4EHPGDHSD17B10LMNATNKS
SCHEMBL312639 0.84 HPGD (0.44) KDM4EHPGDHSD17B10LMNATNKS
SCHEMBL311720 0.83 HPGD (0.59) KDM4EHPGDHSD17B10LMNATNKS
SCHEMBL312875 0.82 KDM4E (0.58) KDM4EHPGDHSD17B10LMNATNKS
SCHEMBL312366 0.82 KDM4E (0.58) KDM4EHPGDHSD17B10LMNATNKS
SCHEMBL312367 0.82 KDM4E (0.52) KDM4EHPGDHSD17B10LMNAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093273-B2 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2012-01-10 US disclosed
EP-2332527-A2 Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2011-06-15 EP disclosed